UA92030C2 - Фармацевтические композиции регулированного высвобождения нестабильных в кислой среде лекарственных средств - Google Patents
Фармацевтические композиции регулированного высвобождения нестабильных в кислой среде лекарственных средствInfo
- Publication number
- UA92030C2 UA92030C2 UAA200803186A UAA200803186A UA92030C2 UA 92030 C2 UA92030 C2 UA 92030C2 UA A200803186 A UAA200803186 A UA A200803186A UA A200803186 A UAA200803186 A UA A200803186A UA 92030 C2 UA92030 C2 UA 92030C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pharmaceutical compositions
- acid labile
- controlled release
- release pharmaceutical
- enteric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Изобретение касается пероральной дозированной формы с энтеросолюбильным покрытием, включающей нестабильный в кислой среде активный фармацевтический ингредиент. Описанные фармацевтические композиции включают энтеросолюбильное покрытие, содержащее пластификатор, по меньшей мере один пленкообразующий агент и необязательно по меньшей мере один агент, который препятствует прилипанию.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05107472 | 2005-08-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA92030C2 true UA92030C2 (ru) | 2010-09-27 |
Family
ID=35253818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200803186A UA92030C2 (ru) | 2005-08-15 | 2006-08-15 | Фармацевтические композиции регулированного высвобождения нестабильных в кислой среде лекарственных средств |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1931316B2 (ru) |
JP (1) | JP5452918B2 (ru) |
CN (1) | CN101242811B (ru) |
AT (1) | ATE457719T2 (ru) |
AU (1) | AU2006281414B2 (ru) |
BR (1) | BRPI0614545B8 (ru) |
CA (1) | CA2619475C (ru) |
DK (1) | DK1931316T4 (ru) |
ES (1) | ES2341284T5 (ru) |
MX (1) | MX2008001558A (ru) |
NZ (1) | NZ565960A (ru) |
PL (1) | PL1931316T5 (ru) |
PT (1) | PT1931316E (ru) |
RU (1) | RU2440101C2 (ru) |
SI (2) | SI1931316T2 (ru) |
UA (1) | UA92030C2 (ru) |
WO (1) | WO2007020259A2 (ru) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
WO2007014896A1 (en) | 2005-07-29 | 2007-02-08 | Solvay Pharmaceuticals Gmbh | Processes for the manufacture of sterilized pancreatin powder |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
CA2677989C (en) * | 2007-02-20 | 2018-04-24 | Eurand Pharmaceuticals Limited | Stable digestive enzyme compositions |
EP2044932A1 (en) | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Mechanical protective layer for solid dosage forms |
WO2009064458A2 (en) | 2007-11-13 | 2009-05-22 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
US10087493B2 (en) | 2008-03-07 | 2018-10-02 | Aptalis Pharma Canada Ulc | Method for detecting infectious parvovirus in pharmaceutical preparations |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
WO2011140106A1 (en) * | 2010-05-03 | 2011-11-10 | Eurand Pharmaceuticals Limited | Micropellet compositions comprising pancreatin containing digestive enzyme mixtures |
MX348118B (es) | 2010-10-01 | 2017-05-26 | Aptalis Pharma Ltd | Formulaciones de pancrelipasa con recubrimiento enterico de baja potencia. |
EP2987499B1 (en) * | 2011-08-08 | 2019-05-08 | Allergan Pharmaceuticals International Limited | Method for dissolution testing of solid compositions containing digestive enzymes |
US10184121B2 (en) | 2013-06-28 | 2019-01-22 | Allergan Pharmaceuticals International Limited | Methods for removing viral contaminants from pancreatic extracts |
RU2679832C2 (ru) | 2013-08-09 | 2019-02-13 | Аллерган Фармасьютикалз Интернэйшнл Лимитед | Композиция пищеварительных ферментов, подходящая для энтерального введения |
EP3215181A1 (en) | 2014-11-05 | 2017-09-13 | Abbott Laboratories GmbH | Processes for producing compositions with improved safety profile comprising pancreatin and compositions suitable for pharmaceutical use |
CN104906565B (zh) * | 2015-05-13 | 2018-06-19 | 西南大学 | 一种胰酶肠溶微丸及其制备方法 |
CN105902513B (zh) * | 2016-05-11 | 2018-10-16 | 广州市义和化工有限公司 | 一种肠溶型金霉素微丸预混剂及其制备方法 |
CN108553439B (zh) * | 2018-04-20 | 2020-10-16 | 广州白云山医药集团股份有限公司白云山制药总厂 | 一种含s-羧甲基-l-半胱氨酸的肠溶片剂 |
RU2706003C1 (ru) | 2019-09-09 | 2019-11-13 | Акционерное общество "АВВА РУС" | Микрогранулы, содержащие панкреатин |
KR102432084B1 (ko) * | 2021-11-16 | 2022-08-12 | 알리코제약(주) | S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2923279B1 (de) | 1979-06-08 | 1980-11-20 | Kali Chemie Pharma Gmbh | Verfahren zur Herstellung von Pankreatin-Pellets |
JPS5855125B2 (ja) * | 1980-03-10 | 1983-12-08 | 信越化学工業株式会社 | 固形薬剤用腸溶性コ−テイング剤組成物 |
JPS57171428A (en) | 1981-04-13 | 1982-10-22 | Sankyo Co Ltd | Preparation of coated solid preparation |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US5225202A (en) | 1991-09-30 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Enteric coated pharmaceutical compositions |
DE4227385A1 (de) | 1992-08-19 | 1994-02-24 | Kali Chemie Pharma Gmbh | Pankreatinmikropellets |
JP2917799B2 (ja) | 1994-03-11 | 1999-07-12 | 田辺製薬株式会社 | 消化管内適所放出型製剤 |
JP3355593B2 (ja) | 1994-08-19 | 2002-12-09 | 信越化学工業株式会社 | 固形腸溶製剤の製造方法 |
JP3435464B2 (ja) * | 1995-01-23 | 2003-08-11 | 信越化学工業株式会社 | 徐放性製剤コーティング用水分散液 |
SE512835C2 (sv) * | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
JP3611456B2 (ja) * | 1997-09-30 | 2005-01-19 | 日研化学株式会社 | テオフィリン徐放性錠剤 |
KR19990072826A (ko) | 1998-02-26 | 1999-09-27 | 우재영 | 판크레아틴장용코팅과립의제조방법 |
UA69413C2 (ru) | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтическая композиция, содержащая сердцевину и энтеросолюбильную оболочку, фармацевтическая композиция в виде сфероидальных гранул, способ получения фармацевтической композиции |
RU2268065C2 (ru) | 1999-03-17 | 2006-01-20 | Зольвай Фармасьютиклз Гмбх | Лекарственное средство, предназначенное для лечения диабета |
US20020146451A1 (en) | 2000-07-15 | 2002-10-10 | Sharma Virender K. | Method for the administration of acid-labile drugs |
IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
US20040213847A1 (en) * | 2003-04-23 | 2004-10-28 | Matharu Amol Singh | Delayed release pharmaceutical compositions containing proton pump inhibitors |
-
2006
- 2006-08-15 SI SI200630639A patent/SI1931316T2/sl unknown
- 2006-08-15 BR BRPI0614545A patent/BRPI0614545B8/pt active IP Right Grant
- 2006-08-15 AU AU2006281414A patent/AU2006281414B2/en active Active
- 2006-08-15 AT AT06778240T patent/ATE457719T2/de active
- 2006-08-15 PL PL06778240T patent/PL1931316T5/pl unknown
- 2006-08-15 EP EP06778240.9A patent/EP1931316B2/en active Active
- 2006-08-15 WO PCT/EP2006/065311 patent/WO2007020259A2/en active Application Filing
- 2006-08-15 RU RU2008109652/15A patent/RU2440101C2/ru active
- 2006-08-15 DK DK06778240.9T patent/DK1931316T4/en active
- 2006-08-15 NZ NZ565960A patent/NZ565960A/en unknown
- 2006-08-15 CN CN200680029688.XA patent/CN101242811B/zh active Active
- 2006-08-15 SI SI200630639T patent/SI1931316T1/sl unknown
- 2006-08-15 MX MX2008001558A patent/MX2008001558A/es active IP Right Grant
- 2006-08-15 PT PT06778240T patent/PT1931316E/pt unknown
- 2006-08-15 ES ES06778240.9T patent/ES2341284T5/es active Active
- 2006-08-15 CA CA2619475A patent/CA2619475C/en active Active
- 2006-08-15 UA UAA200803186A patent/UA92030C2/ru unknown
- 2006-08-15 JP JP2008526492A patent/JP5452918B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
NZ565960A (en) | 2012-03-30 |
MX2008001558A (es) | 2008-02-15 |
BRPI0614545B1 (pt) | 2020-03-31 |
SI1931316T1 (sl) | 2010-06-30 |
WO2007020259A2 (en) | 2007-02-22 |
SI1931316T2 (sl) | 2017-05-31 |
RU2008109652A (ru) | 2009-09-27 |
RU2440101C2 (ru) | 2012-01-20 |
CA2619475C (en) | 2015-09-29 |
EP1931316B1 (en) | 2010-02-17 |
BRPI0614545A2 (pt) | 2011-04-05 |
ATE457719T2 (de) | 2010-03-15 |
PL1931316T5 (pl) | 2017-10-31 |
BRPI0614545B8 (pt) | 2021-05-25 |
ES2341284T3 (es) | 2010-06-17 |
PT1931316E (pt) | 2010-03-29 |
EP1931316A2 (en) | 2008-06-18 |
AU2006281414A1 (en) | 2007-02-22 |
CN101242811B (zh) | 2015-06-17 |
EP1931316B2 (en) | 2017-02-22 |
DK1931316T3 (da) | 2010-05-17 |
JP5452918B2 (ja) | 2014-03-26 |
WO2007020259A3 (en) | 2007-05-10 |
DK1931316T4 (en) | 2017-05-15 |
JP2009504709A (ja) | 2009-02-05 |
CA2619475A1 (en) | 2007-02-22 |
CN101242811A (zh) | 2008-08-13 |
PL1931316T3 (pl) | 2010-07-30 |
AU2006281414B2 (en) | 2011-09-01 |
ES2341284T5 (es) | 2017-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA92030C2 (ru) | Фармацевтические композиции регулированного высвобождения нестабильных в кислой среде лекарственных средств | |
WO2008132712A3 (en) | Combination pharmaceutical compositions | |
WO2014170755A3 (en) | Sustained-release formulations of colchicine and methods of using same | |
WO2004062577A3 (en) | Two or more enteric materials to regulate drug release | |
WO2017171535A8 (en) | Compositions | |
WO2008063910A3 (en) | Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions | |
WO2009117130A3 (en) | Extended release forumulation containing a wax | |
WO2009110005A3 (en) | Modified release pharmaceutical compositions comprising mycophenolate and processes thereof | |
WO2018165404A8 (en) | Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol | |
PH12017502376B1 (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
PH12019500154A1 (en) | Formulation having improved ph-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof | |
WO2006127319A3 (en) | Formulations of suberoylanilide hydroxamic acid and methods for producing same | |
WO2016126058A3 (ko) | 두타스테라이드 함유 고체 분산체 및 이를 포함하는 조성물 | |
MX2019004938A (es) | Cápsula compleja que contiene esomeprazol y método de preparación de esta. | |
JOP20190057A1 (ar) | تركيبات استر كولين حمض الليبويك وطرق تثبيتها إلى منتجات عقار ذات صلة دوائية | |
WO2008039894A3 (en) | Atorvastatin pharmaceutical compositions | |
WO2016091805A3 (de) | Naloxon-monopräparat und mehrschichttablette | |
WO2020032885A3 (en) | Capsule-in-capsule compositions of dabigatran etexilate | |
EP3849560A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE CONTROLLED RELEASE OF WEAK ACID DRUGS AND THEIR USES | |
JP2016504390A5 (ru) | ||
WO2018069805A3 (en) | Method for preparation of liquid oral composition of l-thyroxin | |
MX2019015869A (es) | Nuevas formulaciones orales de belinostat. | |
WO2011128628A3 (en) | Gelled oral pharmaceutical compositions | |
NO20081377L (no) | Farmasoytiske preparater med regulert frigivelse for syrelabile legemidler | |
PH12018550075A1 (en) | An oral osmotic pharmaceutical composition of vildagliptin |